cholestanol - CISMeF

Preferred Label : cholestanol;

MeSH definition : A cholesterol derivative found in human feces, gallstones, eggs, and other biological matter.;

MeSH synonym : 5 alpha-cholestan-3 beta-ol; dihydrocholesterol; cholestan 3 ol; beta-cholestanol; beta cholestanol; cholestan-3-ol; 5 alpha cholestan 3 beta ol;

Related MeSH term : coprosterol; 5 alpha-Cholestan-3 alpha-ol; 5 beta-Cholestan-3 beta-ol; cholestanol, (3alpha, 5beta)-Isomer; 5 beta Cholestan 3 beta ol; beta-Cholestan-3 beta-ol, 5; beta-ol, 5 beta-Cholestan-3; Coprostanol; 5 alpha Cholestan 3 alpha ol; 5 beta-Cholestan-3 alpha-ol;

MeSH CAS label : Cholestan-3-ol, (3beta,5alpha)-;

MeSH Related Number : 5 beta-Cholestan-3 beta-ol; 5 alpha-Cholestan-3 alpha-ol; cholestanol, (3alpha, 5beta)-Isomer; 516-92-7 (3alpha, 5beta-isomer); 80-97-7 (Cholestanol); 360-68-9; 516-95-0;

Registry Number MeSH : 80-97-7;

Related CAS MeSH : 360-68-9 (5 beta-Cholestan-3 beta-ol); 516-95-0 (5 alpha-Cholestan-3 alpha-ol); 516-92-7 (Cholestanol, (3alpha, 5beta)-Isomer);

MeSH annotation : do not confuse with CHOLESTANOLS; do not confuse x-ref DIHYDROCHOLESTEROL with DEHYDROCHOLESTEROLS;

Wikipedia link : https://en.wikipedia.org/wiki/Cholestanol;

Codes EINECS : 201-315-8;

Is substance : O;

UNII : 8M308U816E;

InChIKey : QYIXCDOBOSTCEI-QCYZZNICSA-N;

Details

Origin ID

D004083;

UMLS CUI

C0012282;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- 5-.alpha.-cholestan-3-.alpha.-ol [Substance BNPC]
- Cholestanol [LOINC component]
- Cholestanol (substance) [SNOMED CT concept]
- cholestanol [SNOMED Notion]
CISMeF manual mappings
- 5-.alpha.-cholestan-3-.beta.-ol [Substance BNPC]
Record concept(s)
- 5 alpha-Cholestan-3 alpha-ol [MeSH concept]
- 5 beta-Cholestan-3 beta-ol [MeSH concept]
- cholestanol [MeSH concept]
- cholestanol, (3alpha, 5beta)-Isomer [MeSH concept]
- coprosterol [MeSH concept]
Related MeSH Supplementary Concept(s)
- 2-propenyl-5,6-secocholestan-3-ol [MeSH Supplementary Concept]
- 22,26-azasterol [MeSH Supplementary Concept]
- 3,6-dihydroxycholestan-5-yl sulfate [MeSH Supplementary Concept]
- 3-hydroxy-5-hydroxy-B-norcholestane-6-carboxaldehyde [MeSH Supplementary Concept]
- 3-hydroxycholestan-27-al [MeSH Supplementary Concept]
- 5,6-iminocholestan-3-ol [MeSH Supplementary Concept]
- 7,7-azocholestanol [MeSH Supplementary Concept]
- cholestane-3,27-diol [MeSH Supplementary Concept]
- cholesterol-cholestanol-water adduct [MeSH Supplementary Concept]
See also inter- (CISMeF)
- 5-.beta.-cholestan-3-.beta.-ol [Substance BNPC]
- Coprostanol (substance) [SNOMED CT concept]
- coprostanol [SNOMED Notion]
Semantic type(s)
- Biologically Active Substance [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
UMLS correspondences (same concept)
- 5-.alpha.-cholestan-3-.beta.-ol [Substance BNPC]
- Cholestanol [LOINC component]
- Cholestanol (substance) [SNOMED CT concept]
- cholestanol [SNOMED Notion]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients